Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms

Area of Science:

• Nephrology
• Hematology
• Transplantation Medicine

Background:

• Glomerular disease complicates hematopoietic stem cell transplantation (HSCT) in 1-2% of recipients globally.
• Kidney disease post-HSCT is often multifactorial, necessitating kidney biopsy for diagnosis.
• Existing studies on HSCT-associated glomerular disease are limited to small case series.

Discussion:

• The Yap et al. study provides a comprehensive spectrum of glomerular diseases post-HSCT.
• Thrombotic microangiopathy (38.7%) and membranous nephropathy (25.8%) are the most prevalent glomerular diseases.
• Other identified glomerular diseases include mesangial proliferative glomerulonephritis, minimal change disease, focal segmental glomerulosclerosis, and membranoproliferative glomerulonephritis.

Key Insights:

• This research defines the pathological landscape of glomerular complications after HSCT.
• Understanding this spectrum aids in targeted diagnosis and management of kidney complications.
• The findings highlight the need for increased awareness and research into HSCT-related nephrotoxicity.

Outlook:

• Further research is needed to elucidate the mechanisms driving these glomerular diseases post-HSCT.
• Developing preventative and therapeutic strategies for HSCT-associated kidney disease is crucial.
• Long-term follow-up studies are essential to assess the prognosis of patients with these glomerular conditions.